1. It is important to consider immune-related adverse events in patients coming in with new cutaneous reactions, even in patients who have not recently started a new immunotherapy regimen, as reactions can occur months later.
2. Pruritus and morbilliform rashes tend to be the most common adverse event related to immunotherapy, and often do not require interruption of treatment.
3. Red flags of more severe cutaneous adverse events include mucous membrane involvement, skin sloughing, large body surface area involvement, end organ dysfunction, presence of bullae, and associated fever.
4. Treatment will vary by Grade and includes topical steroids and antipruritic medications, as well as oral antihistamines.
5. Diagnosis may require Dermatology consultation and skin biopsy. Progression of cutaneous toxicities with serial photographs can be helpful in evaluating immune related cutaneous adverse events.